Company: BLZRW
Filing Date: 2025-08-25
Form Type: S-1/A
Source: 0001213900-25-080183
Chunk: 333

Company: Trailblazer Acquisition Corp.
Filing Date: 2025-08-25
Form: S-1/A
Chunk 333
---
(a)(2) of the Securities Act. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 23,000,000 units if the underwriters’ over -allotmentoption is exercised in full and therefore that such founder shares would represent 20% of the outstanding shares after this offering. Up to 750,000 of these shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentoption is exercised.

II-1

Our sponsor is an accredited investor for purposes of Rule 501 of Regulation D. Each of the equity holders in our sponsor is an accredited investor under Rule 501 of Regulation D. The sole business of our sponsor is to act as the company’s sponsor in connection with this offering. The limited liability company agreement of our sponsor provides that its membership interests may only be transferred to our officers or directors or other persons affiliated with our sponsor, or in connection with estate planning transfers. Our sponsor and Cantor Fitzgerald & Co., the representative of the underwriters, have committed to, pursuant to written agreements, purchase an aggregate of 4,000,000 private placement warrants, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per warrant, or $6,000,000 in the aggregate, in a private placement that will close simultaneously with the closing of this offering. Of those 4,000,000 private placement warrants, our sponsor has agreed to purchase 2,666,667 warrants and Cantor Fitzgerald & Co. has agreed to purchase 1,333,333 warrants. This issuance will be made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No underwriting discounts or commissions were paid with respect to such sales. Item 16. Exhibits and Financial Statement Schedules. Exhibit Index

| Exhibit No. |     | Description                                                                                                                      |
| 1.1*        |     | Form of Underwriting Agreement.                                                                                                  |
| 3.1*        |     | Memorandum and Articles of Association.                                                                                          |
| 3.2*        |     | Form of Amended and Restated Memorandum and Articles of Association.                                                             |
| 4.1*        |     | Specimen Unit Certificate.                                                                                                       |
| 4.2*        |     | Specimen Ordinary Share Certificate.                                                                                             |
|